Carl Zeiss Meditec Q1 Earnings Call Highlights
Carl Zeiss Meditec (ETR:AFX) reported a weaker-than-expected start to fiscal 2025/26, as management cited currency headwinds, an unfavorable product mix, and challenges in China and the U.S. as key drivers of lower revenue and sharply reduced profitability in the first quarter.
Chief Executive Offi
Source link